IDA Acceptability Study (India)

Assess the overall acceptability of the 3-drug treatment in the community as compared to the 2-drug treatment

Sites

WHO Region: SEARO

Notes

Treatment acceptability study following the Community-Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis in India. See Triple Drug Therapy (India).

Email primary contact

Please log in or register